Eyeonic, an Australian-owned cloud-based artificial intelligence-powered platform to detect glaucoma, continues to build its international presence, with more than 40,000 tests performed since its

More than 400 community members have written to Macular Disease Foundation Australia (MDFA) supporting its call for the Government to delay planned changes to

Groundbreaking research into the eyes of the world’s longest-living vertebrate could pave the way for new therapies to combat glaucoma and age-related macular degeneration,

TheiaNova has dosed the first patient in a proof-of-concept clinical study evaluating its investigational eye drop therapy for keratoconus.